FOLFOX/Bevacizumab With Onartuzumab (MetMAb) Versus Placebo as First-Line Treatment in Patients With Metastatic Colorectal Cancer
Clinical trial NCT01418222 · COMPLETED
Trial details
- NCT number
- NCT01418222
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-14
- Primary completion
- 2013-03-18
- Enrollment
- 194
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.